Results
|
|
41.
|
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial. [electronic resource] by
- Earl, Helena M
- Hiller, Louise
- Dunn, Janet A
- Blenkinsop, Clare
- Grybowicz, Louise
- Vallier, Anne-Laure
- Abraham, Jean
- Thomas, Jeremy
- Provenzano, Elena
- Hughes-Davies, Luke
- Gounaris, Ioannis
- McAdam, Karen
- Chan, Stephen
- Ahmad, Rizvana
- Hickish, Tamas
- Houston, Stephen
- Rea, Daniel
- Bartlett, John
- Caldas, Carlos
- Cameron, David A
- Hayward, Larry
Producer: 20150831
In:
The Lancet. Oncology vol. 16
Availability: No items available.
|
|
|
42.
|
Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial. [electronic resource] by
- Rea, Daniel
- Francis, Adele
- Wallis, Matthew
- Thomas, Jeremy
- Bartlett, John
- Bowden, Sarah
- Dodwell, David
- Fallowfield, Lesley
- Gaunt, Claire
- Hanby, Andrew
- Jenkins, Valerie
- Matthews, Lucy
- Pinder, Sarah
- Pirrie, Sarah
- Reed, Malcolm
- Wilcox, Margaret
- Roberts, Tracy
- Kirwan, Cliona
- Brookes, Cassandra
- Fairbrother, Patricia
- Billingham, Lucinda
- Evans, Andrew
- Young, Jennie
Producer: 20190318
In:
Annals of surgical oncology vol. 24
Availability: No items available.
|
|
|
43.
|
Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial. [electronic resource] by
- Fernando, Indrajit N
- Bowden, Sarah J
- Herring, Kathryn
- Brookes, Cassandra L
- Ahmed, Ikhlaaq
- Marshall, Andrea
- Grieve, Robert
- Churn, Mark
- Spooner, David
- Latief, Talaat N
- Agrawal, Rajiv K
- Brunt, Adrian M
- Stevens, Andrea
- Goodman, Andrew
- Canney, Peter
- Bishop, Jill
- Ritchie, Diana
- Dunn, Janet
- Poole, Christopher J
- Rea, Daniel W
Producer: 20200625
In:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 142
Availability: No items available.
|
|
|
44.
|
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial. [electronic resource] by
- Bartlett, John M S
- Brookes, Cassandra L
- Robson, Tammy
- van de Velde, Cornelis J H
- Billingham, Lucinda J
- Campbell, Fiona M
- Grant, Margaret
- Hasenburg, Annette
- Hille, Elysée T M
- Kay, Charlene
- Kieback, Dirk G
- Putter, Hein
- Markopoulos, Christos
- Kranenbarg, Elma Meershoek-Klein
- Mallon, Elizabeth A
- Dirix, Luc
- Seynaeve, Caroline
- Rea, Daniel
Producer: 20110617
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29
Availability: No items available.
|
|
|
45.
|
The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancer. [electronic resource] by
- Hayward, Steven
- Gachehiladze, Mariam
- Badr, Nahla
- Andrijes, Regina
- Molostvov, Guerman
- Paniushkina, Liliia
- Sopikova, Barbora
- Slobodová, Zuzana
- Mgebrishvili, Giorgi
- Sharma, Nisha
- Horimoto, Yoshiya
- Burg, Dominic
- Robertson, Graham
- Hanby, Andrew
- Hoar, Fiona
- Rea, Daniel
- Eckhardt, Bedrich L
- Ueno, Naoto T
- Nazarenko, Irina
- Long, Heather M
- van Laere, Steven
- Shaaban, Abeer M
- Berditchevski, Fedor
Producer: 20200917
In:
The Journal of pathology vol. 251
Availability: No items available.
|
|
|
46.
|
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial. [electronic resource] by
- Thomas, Jeremy St John
- Provenzano, Elena
- Hiller, Louise
- Dunn, Janet
- Blenkinsop, Clare
- Grybowicz, Louise
- Vallier, Anne-Laure
- Gounaris, Ioannis
- Abraham, Jean
- Hughes-Davies, Luke
- McAdam, Karen
- Chan, Stephen
- Ahmad, Rizvana
- Hickish, Tamas
- Houston, Stephen
- Rea, Daniel
- Caldas, Carlos
- Bartlett, John Ms
- Cameron, David Allan
- Hayward, Richard Laurence
- Earl, Helena Margaret
Producer: 20180503
In:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 30
Availability: No items available.
|
|
|
47.
|
Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial. [electronic resource] by
- Roseweir, Antonia K
- Bennett, Lindsay
- Dickson, Ashley
- Cheng, Kelvin
- Quintayo, Mary-Anne
- Bayani, Jane
- McMillan, Donald C
- Horgan, Paul G
- van de Velde, Cornelis J H
- Seynaeve, Caroline
- Hasenburg, Annette
- Kieback, Dirk G
- Markopoulos, Christos
- Dirix, Luc Y
- Rea, Daniel W
- Mallon, Elizabeth A
- Bartlett, John M S
- Edwards, Joanne
Producer: 20190729
In:
Journal of the National Cancer Institute vol. 110
Availability: No items available.
|
|
|
48.
|
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others. [electronic resource] by
- Bartlett, John M S
- Bayani, Jane
- Marshall, Andrea
- Dunn, Janet A
- Campbell, Amy
- Cunningham, Carrie
- Sobol, Monika S
- Hall, Peter S
- Poole, Christopher J
- Cameron, David A
- Earl, Helena M
- Rea, Daniel W
- Macpherson, Iain R
- Canney, Peter
- Francis, Adele
- McCabe, Christopher
- Pinder, Sarah E
- Hughes-Davies, Luke
- Makris, Andreas
- Stein, Robert C
Producer: 20170711
In:
Journal of the National Cancer Institute vol. 108
Availability: No items available.
|
|
|
49.
|
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also. [electronic resource] by
- Bartlett, John M S
- McConkey, Christopher C
- Munro, Alison F
- Desmedt, Christine
- Dunn, Janet A
- Larsimont, Denis P
- O'Malley, Frances P
- Cameron, David A
- Earl, Helena M
- Poole, Christopher J
- Shepherd, Lois E
- Cardoso, Fatima
- Jensen, Maj-Britt
- Caldas, Carlos
- Twelves, Christopher J
- Rea, Daniel W
- Ejlertsen, Bent
- Di Leo, Angelo
- Pritchard, Kathleen I
Producer: 20150811
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 33
Availability: No items available.
|
|
|
50.
|
Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial analysis. [electronic resource] by
- Fontein, Duveken B Y
- Seynaeve, Caroline
- Hadji, Peyman
- Hille, Elysée T M
- van de Water, Willemien
- Putter, Hein
- Kranenbarg, Elma Meershoek-Klein
- Hasenburg, Annette
- Paridaens, Robert J
- Vannetzel, Jean-Michel
- Markopoulos, Christos
- Hozumi, Yasuo
- Bartlett, John M S
- Jones, Stephen E
- Rea, Daniel William
- Nortier, Johan W R
- van de Velde, Cornelis J H
Producer: 20130828
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31
Availability: No items available.
|
|
|
51.
|
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. [electronic resource] by
- Poole, Christopher J
- Earl, Helena M
- Hiller, Louise
- Dunn, Janet A
- Bathers, Sarah
- Grieve, Robert J
- Spooner, David A
- Agrawal, Rajiv K
- Fernando, Indrajit N
- Brunt, A Murray
- O'Reilly, Susan M
- Crawford, S Michael
- Rea, Daniel W
- Simmonds, Peter
- Mansi, Janine L
- Stanley, Andrew
- Harvey, Peter
- McAdam, Karen
- Foster, Liz
- Leonard, Robert C F
- Twelves, Christopher J
Producer: 20061109
In:
The New England journal of medicine vol. 355
Availability: No items available.
|
|
|
52.
|
Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER [electronic resource] by
- Robertson, John F R
- Coleman, Robert E
- Cheung, Kwok-Leung
- Evans, Abigail
- Holcombe, Chris
- Skene, Anthony
- Rea, Daniel
- Ahmed, Samreen
- Jahan, Ali
- Horgan, Kieran
- Rauchhaus, Petra
- Littleford, Roberta
- Cheung, S Y Amy
- Cullberg, Marie
- de Bruin, Elza C
- Koulai, Loumpiana
- Lindemann, Justin P O
- Pass, Martin
- Rugman, Paul
- Schiavon, Gaia
- Deb, Rahul
- Finlay, Pauline
- Foxley, Andrew
- Gee, Julia M W
Producer: 20210122
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26
Availability: No items available.
|
|
|
53.
|
Pathway-based subnetworks enable cross-disease biomarker discovery. [electronic resource] by
- Haider, Syed
- Yao, Cindy Q
- Sabine, Vicky S
- Grzadkowski, Michal
- Stimper, Vincent
- Starmans, Maud H W
- Wang, Jianxin
- Nguyen, Francis
- Moon, Nathalie C
- Lin, Xihui
- Drake, Camilla
- Crozier, Cheryl A
- Brookes, Cassandra L
- van de Velde, Cornelis J H
- Hasenburg, Annette
- Kieback, Dirk G
- Markopoulos, Christos J
- Dirix, Luc Y
- Seynaeve, Caroline
- Rea, Daniel W
- Kasprzyk, Arek
- Lambin, Philippe
- Lio', Pietro
- Bartlett, John M S
- Boutros, Paul C
Producer: 20190422
In:
Nature communications vol. 9
Availability: No items available.
|
|
|
54.
|
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial. [electronic resource] by
- Earl, Helena M
- Hiller, Louise
- Howard, Helen C
- Dunn, Janet A
- Young, Jennie
- Bowden, Sarah J
- McDermaid, Michelle
- Waterhouse, Anna K
- Wilson, Gregory
- Agrawal, Rajiv
- O'Reilly, Susan
- Bowman, Angela
- Ritchie, Diana M
- Goodman, Andrew
- Hickish, Tamas
- McAdam, Karen
- Cameron, David
- Dodwell, David
- Rea, Daniel W
- Caldas, Carlos
- Provenzano, Elena
- Abraham, Jean E
- Canney, Peter
- Crown, John P
- Kennedy, M John
- Coleman, Robert
- Leonard, Robert C
- Carmichael, James A
- Wardley, Andrew M
- Poole, Christopher J
Producer: 20170824
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|
|
|
55.
|
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. [electronic resource] by
- Earl, Helena M
- Hiller, Louise
- Vallier, Anne-Laure
- Loi, Shrushma
- McAdam, Karen
- Hughes-Davies, Luke
- Harnett, Adrian N
- Ah-See, Mei-Lin
- Simcock, Richard
- Rea, Daniel
- Raj, Sanjay
- Woodings, Pamela
- Harries, Mark
- Howe, Donna
- Raynes, Kerry
- Higgins, Helen B
- Wilcox, Maggie
- Plummer, Chris
- Mansi, Janine
- Gounaris, Ioannis
- Mahler-Araujo, Betania
- Provenzano, Elena
- Chhabra, Anita
- Abraham, Jean E
- Caldas, Carlos
- Hall, Peter S
- McCabe, Christopher
- Hulme, Claire
- Miles, David
- Wardley, Andrew M
- Cameron, David A
- Dunn, Janet A
Producer: 20190723
In:
Lancet (London, England) vol. 393
Availability: No items available.
|
|
|
56.
|
Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data. [electronic resource] by
- Zardavas, Dimitrios
- Te Marvelde, Luc
- Milne, Roger L
- Fumagalli, Debora
- Fountzilas, George
- Kotoula, Vassiliki
- Razis, Evangelia
- Papaxoinis, George
- Joensuu, Heikki
- Moynahan, Mary Ellen
- Hennessy, Bryan T
- Bieche, Ivan
- Saal, Lao H
- Stal, Olle
- Iacopetta, Barry
- Jensen, Jeanette Dupont
- O'Toole, Sandra
- Lopez-Knowles, Elena
- Barbaraeschi, Mattia
- Noguchi, Shinzaburo
- Azim, Hatem A
- Lerma, Enrique
- Bachelot, Thomas
- Wang, Qing
- Perez-Tenorio, Gizeh
- Can de Velde, Cornelis J H
- Rea, Daniel W
- Sabine, Vicky
- Bartlett, John M S
- Sotiriou, Christos
- Michiels, Stefan
- Loi, Sherene
Producer: 20190801
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36
Availability: No items available.
|